Heather Fairhead is the CEO of Phico Therapeutics Ltd. and has been a Board Member of BEAM Alliance, Biotechs of Europe innovating in Anti-Microbial Resistance since 2018.
Heather Fairhead obtained their PhD in Molecular Microbiology from the University of Sheffield between 1993 and 1996. Heather previously obtained their BSc (1st class) Hons in Biotechnology from the University of Nottingham between 1989 and 1993.
Current role